September Newsmakers

Kohl: Work with Komen provides 'courage and determination' for her cancer fight (WRAL)
Features Rachel Blitzbau, MD, PhD

Understanding the Different Perspectives on Cost and Value in Cancer Care (The ASCO Post)
Features Yousuf Zafar, MD, MHS

Immunotherapy offers a promising bet against brain cancer (Nature
Features John Sampson, MD, PhD

Heart Problems: Investigating the Cardiac Side Effects of Cancer Treatments (National Cancer Institute)
Features Susan Dent, MD

NC to receive $2M for breast cancer research from Susan G. Komen (WRAL)
Features Donald McDonnell, PhD

What Is Active Surveillance for Breast Cancer? (U.S. News & World Report)
Features E. Shelley Hwang, MD

What is Glioblastoma? The brain cancer that killed McCain is hard to treat (WHAS-11 TV)
Duke brain cancer researchers 

Significant breakthrough achieved in cancer genomics (Markets Insider)
Hai Yan, MD, PhD

Beyond 'Genes of Interest,' All Genetic Testing Helps Outcomes and Prevention (Cure)
Angeles Alvarez Secord, MD

Survey: Cancer Patients Will Pay Anything for Treatment (MedPage Today)
Fumiko Chino, MD

Erba Transitions to Director of Leukemia Program at Duke Cancer Institute (Targeted Oncology)
Harry Erba, MD, PhD

Solving the Mystery of How ALL Enters the Central Nervous System (Oncology Times)
Dorothy Sipkins, MD, PhD

WATCH: Dr. Riedel on the Treatment Landscape of Uterine Sarcomas (OncLive)
Richard Riedel, MD

WATCH: Dr. Riedel on the Role of Immunotherapy in Uterine Sarcoma (OncLive)
Richard Riedel, MD

Dr. George on the Results of the Abi Race Study (OncLive)
Features Daniel George, MD

Dr. Brander on the Treatment of Relapsed/Refractory CLL (OncLive)
Feaures Danielle Brander, MD

WATCH: A ‘Misunderstood’ Disease (Wolters Kluwer)
Features Daniel George, MD

Researchers make breakthrough in understanding aggressive brain cancer (The Chronicle)
Features Peter Fecci, MD, PhD

Decision-IQ: Genetic Risk Assessment and Testing for Hereditary Ovarian Cancer (Clinical Practice Today)
Features Andrew Berchuck, MD

Rebecca Previs, MD, Awarded AAOGF, GOG Scholarship for Ovarian Cancer Research (Duke OBGyn)

Cellular pumps protect the gut from toxins (Duke-NUS press release)
Features Duke-Nus Medical School researchers


Hysterectomy with sentinel lymph node biopsy in the setting of pre-operative diagnosis of endometrial intraepithelial neoplasia: A cost-effectiveness analysis. Gynecologic Oncology. September 2018. Stephanie L. Lim, Haley A. Moss, Angeles Alvarez Secord, Paula S. Lee, Laura J. Havrilesky, Brittany A. Davidson.

Near-infrared fluorescence for detection of sentinel lymph nodes in women with cervical and uterine cancers (FILM): a randomised, phase 3, multicentre, non-inferiority trial. The Lancet Oncology. August 21, 2018. Prof Michael Frumovitz, MD; Prof Marie Plante, MD; Paula S Lee, MD; Samith Sandadi, MD; James F Lilja, MD; Pedro F Escobar, MD; Lilian T Gien, MD; Diana L Urbauer, MS; Prof Nadeem R Abu-Rustum, MD.

Going for Broke: A Longitudinal Study of Patient-Reported Financial Sacrifice in Cancer Care. Journal of Oncology Practice. Aug 23, 2018. Fumiko Chino, Jeffrey M. Peppercorn, Christel Rushing, Jonathan Nicolla, Arif H. Kamal, Ivy Altomare, Greg Samsa, and S. Yousuf Zafar.

Geographic Access to CT for Lung Cancer Screening: A Census Tract-Level Analysis of Cigarette Smoking in the United States and Driving Distance to a CT Facility. Journal of the American College of Radiology. July 2018. Tina D. Tailor, MD; Kingshuk R. Choudhury, PhD; Betty C. Tong, MD, MHS, MS; Jared D. Christensen, MD; Julie A. Sosa, MD, MA; Geoffrey D. Rubin, MD, MBA.

Interrogating the protein interactomes of RAS isoforms identifies PIP5K1A as a KRAS-specific vulnerability. Nature Communications. September 7, 2018. Hema Adhikari; Christopher Counter